Novel anti-viral formulation to prevent rhinovirus and influenza
Ended Cooperative Agreement Awarded Last action
- Award ID
- R43IP001129
- Recipient
-
Applied Biological Laboratories Inc. UEI YKB3A7BQ3KJ5
- Awarding agency
-
Office of Financial Resources
Centers for Disease Control and Prevention, Department of Health and Human Services
- Obligated
- $224,399
Award facts
- Assistance listing
- 93.061 Innovations in Applied Public Health Research
- Completion date
- Funding agency
- National Center for Immunization and Respiratory Diseases Centers for Disease Control and Prevention, Department of Health and Human Services
- Place of performance
- Brooklyn, NY, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $224,399 |
Quick answers
Who received award R43IP001129?
R43IP001129 was awarded to Applied Biological Laboratories Inc. by Office of Financial Resources (Centers for Disease Control and Prevention) on September 1, 2019.
How much is award R43IP001129 worth?
$224,399 has been obligated on R43IP001129.
Which agency awarded R43IP001129?
Office of Financial Resources (Centers for Disease Control and Prevention) awarded R43IP001129, with funding from National Center for Immunization and Respiratory Diseases (Centers for Disease Control and Prevention).
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award